Strengthening the Local Production of Essential Generic Drugs in Least Developed/Developing Countries
(2010; 76 pages)


The World Health Organization (WHO) considers Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), tuberculosis (TB) and malaria as the three big killers. Enhancing availability and affordability of the essential pharmaceuticals against the pandemics would improve the public health situation in developing countries and would enable the population to fully mobilize their productive capabilities for enhanced economic growth. The project “Strengthening the local production of essential generic drugs in Least Developed and Developing Countries” is co-funded by the German Government and UNIDO. The project covers activities in 14 countries, with a total budget of 3.3 million Euros over five years. The project is being implemented at three levels: i) macro-level policy advice, ii) meso-level institutional capacity building, and iii) micro-level direct support to enterprises.

The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 1, 2019